# French National Institute of Health and Medical Research

> French biomedical research institute

**Wikidata**: [Q1474517](https://www.wikidata.org/wiki/Q1474517)  
**Wikipedia**: [English](https://en.wikipedia.org/wiki/Inserm)  
**Source**: https://4ort.xyz/entity/french-national-institute-of-health-and-medical-research

## Summary
The French National Institute of Health and Medical Research (INSERM) is a French biomedical research institute established in 1964, dedicated to advancing scientific knowledge in health and medicine. It is a key player in biomedical research, affiliated with the Ministry of Higher Education and Research, and operates under the legal framework of a national public establishment. INSERM conducts cutting-edge research across various disciplines, including biochemistry, genetics, and epidemiology, contributing significantly to medical advancements and public health.

## Key Facts
- **Established in 1964** as the Institut National de la Santé et de la Recherche Médicale (INSERM), with its founding date officially recognized on July 18, 1964.
- **Headquartered in Paris**, with its main office located at 101 Rue de Tolbiac, 75654 Cedex 13, Paris.
- **Affiliated with the Ministry of Higher Education and Research** since 1983, and previously with the Ministry of Labour, Health and Solidarity from 1964.
- **Operates as a national public establishment of an administrative nature**, governed by French legal categories.
- **Has a budget of €1.073 billion** as of 2022, reflecting its significant financial investment in research.
- **Employs approximately 14,292 staff** as of 2022, including researchers and support personnel.
- **Member of the Couperin Consortium**, a network for life sciences and health research.
- **Part of ELIXIR France**, contributing to European bioinformatics infrastructure.
- **Awards prestigious research prizes**, including the Prix International de l’INSERM and the Inserm Grand Prix.
- **Conducts research in diverse fields**, including biochemistry, genetics, and epidemiology, with subsidiaries such as the Centre d'Immunologie de Marseille-Luminy and the Institute of Myology.

## FAQs
### Q: What is the primary mission of INSERM?
A: INSERM's primary mission is to conduct fundamental and applied biomedical research to advance scientific knowledge in health and medicine, contributing to public health and medical innovation.

### Q: How many employees does INSERM have?
A: As of 2022, INSERM employs approximately 14,292 staff, including researchers and support personnel.

### Q: What are some of INSERM's notable achievements?
A: INSERM has received prestigious awards such as the Prix International de l’INSERM and the Inserm Grand Prix, and it operates subsidiaries like the Centre d'Immunologie de Marseille-Luminy, contributing to significant advancements in biomedical research.

### Q: What is INSERM's budget?
A: INSERM's budget is €1.073 billion as of 2022, reflecting its substantial investment in research and development.

### Q: Who are some key figures associated with INSERM?
A: Key figures include Pierre Étévenon, an Honorary Director of Research, and former chairpersons such as Gilles Bloch and Yves Lévy, who have led the institute during various periods.

## Why It Matters
INSERM plays a crucial role in advancing biomedical research in France and globally. As a leading research institute, it contributes to medical breakthroughs, public health initiatives, and scientific innovation. By funding and conducting high-quality research, INSERM addresses critical health challenges, such as infectious diseases, cancer, and neurodegenerative disorders. Its work supports the development of new treatments, therapies, and diagnostic tools, ultimately improving patient outcomes and enhancing the quality of life. INSERM's collaborative network and prestigious awards further solidify its reputation as a key player in the scientific community. The institute's commitment to scientific integrity and its role in shaping the future of medicine make it an essential institution for both France and the international research community.

## Notable For
- **Prestigious research awards**, including the Prix International de l’INSERM and the Inserm Grand Prix, recognizing outstanding contributions to biomedical research.
- **Subsidiaries and research centers**, such as the Centre d'Immunologie de Marseille-Luminy and the Institute of Myology, which conduct specialized research in immunology and myology.
- **Membership in key scientific networks**, including the Couperin Consortium and ELIXIR France, enhancing its global research collaborations.
- **Significant budget and staff**, with a €1.073 billion budget in 2022 and 14,292 employees, reflecting its substantial investment in research.
- **Historical significance**, having been established in 1964 and evolving into a major player in biomedical research, with a strong affiliation with the Ministry of Higher Education and Research.

## Body
### Founding and Legal Framework
INSERM was established on July 18, 1964, and operates as a national public establishment of an administrative nature, governed by French legal categories. It is affiliated with the Ministry of Higher Education and Research since 1983, following its initial association with the Ministry of Labour, Health and Solidarity.

### Headquarters and Infrastructure
The institute's headquarters are located at 101 Rue de Tolbiac, 75654 Cedex 13, Paris. INSERM has a significant infrastructure, including subsidiaries such as the Centre d'Immunologie de Marseille-Luminy, the Centre de Recherche des Cordeliers, and the Institute of Myology, which conduct specialized research in various fields.

### Research and Budget
INSERM conducts fundamental and applied biomedical research, with a budget of €1.073 billion as of 2022. The institute employs approximately 14,292 staff, including researchers and support personnel. It is part of ELIXIR France, contributing to European bioinformatics infrastructure, and is a member of the Couperin Consortium, a network for life sciences and health research.

### Awards and Recognition
INSERM awards prestigious research prizes, including the Prix International de l’INSERM and the Inserm Grand Prix. The institute has received numerous accolades for its contributions to biomedical research, solidifying its reputation as a leading institution in the field.

### Key Figures and Leadership
Key figures associated with INSERM include Pierre Étévenon, an Honorary Director of Research, and former chairpersons such as Gilles Bloch and Yves Lévy, who have led the institute during various periods. These leaders have played significant roles in shaping INSERM's mission and achievements.

### Memberships and Collaborations
INSERM is a member of several scientific networks, including the Couperin Consortium, the French National Alliance for Life Sciences and Health, and the European Network of Research Integrity. These collaborations enhance its global research impact and contribute to scientific advancements.

## References

1. [Source](https://www.legifrance.gouv.fr/affichTexte.do?cidTexte=LEGITEXT000006064285&dateTexte=vig)
2. GRID Release 2017-01-10
3. CiNii Research
4. [Source](http://www.elixir-europe.org/about-us/who-we-are/nodes/france)
5. SIRENE
6. [Source](http://www.couperin.org/presentation/notre-organisation/les-membres-de-couperin/items?cid=162id=221lang=fr)
7. [Source](https://discovery.renater.fr/renater/)
8. [Source](https://web.archive.org/web/20240216160204/https://www.enrio.eu/members/)
9. [Source](https://web.archive.org/web/20231109092552/https://coara.eu/coalition/membership/)
10. [Source](https://eosc.eu/members/)
11. [Journal officiel de la République française](https://www.legifrance.gouv.fr/jo_pdf.do?id=JORFTEXT000037647458)
12. [Journal officiel de la République française](https://www.legifrance.gouv.fr/jo_pdf.do?id=JORFTEXT000037485544)
13. [Le Monde](https://www.lemonde.fr/politique/article/2018/10/13/une-presidente-par-interim-de-l-inserm-nommee-apres-le-depart-d-yves-levy-pour-le-conseil-d-etat_5368949_823448.html)
14. [Journal officiel de la République française](https://www.legifrance.gouv.fr/jorf/id/JORFTEXT000047080502)
15. [Journal officiel de la République française](https://www.legifrance.gouv.fr/jorf/id/JORFTEXT000000613520)
16. [Journal officiel de la République française](https://www.legifrance.gouv.fr/jorf/id/JORFTEXT000020417707)
17. [Le Monde](https://www.lemonde.fr/planete/article/2007/10/08/christian-brechot-demissionne-de-l-inserm_964458_3244.html)
18. [Journal officiel de la République française](https://www.legifrance.gouv.fr/jorf/id/JORFTEXT000000469743)
19. [Journal officiel de la République française](https://www.legifrance.gouv.fr/jorf/id/JORFTEXT000000679643/)
20. [Source](https://www.inserm.fr/nous-connaitre/histoire-de-linserm/)
21. Freebase Data Dumps. 2013
22. Czech National Authority Database
23. [Source](https://fr.calameo.com/read/0051544504528e4ab4aa3)
24. [French decree](https://www.legifrance.gouv.fr/loda/id/LEGITEXT000006064285)
25. [Source](https://www.inserm.fr/nous-connaitre/inserm-en-coup-oeil/)
26. GRID Release 2015-12-14
27. GRID Release 2016-12-06
28. [Source](https://www.inserm.fr/connaitre-inserm/missions/budget)
29. [Source](https://www.inserm.fr/nous-connaitre/budget/)
30. [Source](https://tools.wmflabs.org/whois/gateway.py?lookup=true&ip=193.52.143.0)
31. [Source](https://tools.wmflabs.org/whois/gateway.py?lookup=true&ip=193.49.127.0)
32. [Source](https://apps.db.ripe.net/search/lookup.html?source=ripe&key=2001:660:3014::/48&type=inet6num)
33. [Source](https://apps.db.ripe.net/search/lookup.html?source=ripe&key=2001:660:3306::/48&type=inet6num)
34. [Source](https://orcid.org/signin)
35. Microsoft Academic Knowledge Graph
36. YouTube API